{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04018",
    "Peptide Name": "Myxinidin G1A (synthetic AMPs, XXA, UCLL1c)",
    "Source": "Amino acid substitution, Ala-scan",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "AIHDILKYGKPS",
    "Sequence Length": 12,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 3,
    "Boman Index": 0.87,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "33%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (91.67%) toMyxinidinActivity: active against E-coli ATCC 11219 (MIC >50 uM), P. aeruginosa ATCC 13388 (MIC 10 uM), S. enterica serovar Typhimurium ATCC 14028 (MIC 2.2 uM), K-pneumoniae ATCC 10031 (MIC >50 uM), S. aureus ATCC 6538 (MIC 10 uM).Toxicity: human RBC (5%), 22% hemolysis at 200 uM (HC50> 200 uM, low hemo.lytic).Structure: helical in 50% TFE.",
    "Author": "Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.2014",
    "Reference": "Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. doi: 10.1128/AAC.02395-14.PubMed",
    "Title": "Structural insights into and activity analysis of the antimicrobial peptide myxinidin."
  },
  "3D Structure": []
}